A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System

CompletedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

July 9, 2016

Study Completion Date

July 9, 2016

Conditions
Lung CancerLung NeoplasmsCancer of LungCancer of the LungNeoplasms, LungNeoplasms, PulmonaryPulmonary CancerPulmonary NeoplasmsCarcinoma, Non-small-cell LungAdenocarcinomaSquamous Cell Carcinoma
Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Clearbridge Biomedics

INDUSTRY

lead

Mayo Clinic

OTHER